Genetic Mutations in Brain Tumors Could Turn Out Useful - Neuroscience News
Por um escritor misterioso
Last updated 13 março 2025

Scientists have discovered genetic mutations in brain tumors that alter brain tumor metabolism. The scientists report that cells with defective IDH1 or IDH2 genes had over 100 more metabolites with altered concentrations than cells without defective IDH1 or IDH2 genes. One such metabolite is the very common brain metabolite, N-acetyl-aspartyl-glutamate, or NAAG. Concentration levels of NAAG were 50 times less in cells with IDH1 defective genes. Armed with this research, scientists may be able to improve identification and targeting of […]
Neuroscience News provides research news for neuroscience, neurology, psychology, AI, brain science, mental health, robotics and cognitive sciences.
Neuroscience News provides research news for neuroscience, neurology, psychology, AI, brain science, mental health, robotics and cognitive sciences.

Head injuries could be a risk factor for developing brain cancer

How social isolation affects the brain

Artificial Intelligence Predicts Genetics of Cancerous Brain Tumors in Under 90 Seconds - Neuroscience News

Brain Hijackers: How cancer manipulates the brain to help it grow

A Protein Guardian of Our Genes and Immune System Identified - Neuroscience News

Neuronal and tumourigenic boundaries of glioblastoma plasticity: Trends in Cancer

A new branch of oncology, cancer neuroscience, offers hope for hard-to-treat brain tumors, News Center

Study offers new insight about gene expression and neurological disease heritability

Glioblastoma Cells Imitate Immature Neurons to Invade the Brain

Genetically engineered cerebral organoids model brain tumor formation

Longitudinal changes of brain microstructure and function in nonconcussed female rugby players

The molecule that could treat brain injuries and boost your fading memory

Cancers, Free Full-Text

Model Predicts Better Outcomes for Brain Tumors with Gene Mutation - News Center

Insights and opportunities at the crossroads of cancer and neuroscience